JMP Securities Starts Syros Pharmaceuticals (SYRS) at Market Outperform
Tweet
Share
E-mailGet Alerts SYRS Hot Sheet
Price: $5.09 +2.00%
Rating Summary:
8 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 11 | New: 13
Rating Summary:
8 Buy, 1 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 11 | New: 13
Join SI Premium – FREE
JMP Securities initiated coverage on Syros Pharmaceuticals (NASDAQ: SYRS) with a Market Outperform rating and a price target of $22.00.
For an analyst ratings summary and ratings history on Syros Pharmaceuticals click here. For more ratings news on Syros Pharmaceuticals click here.
Shares of Syros Pharmaceuticals closed at $11.45 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lake Street Capital Markets Starts Research Solutions Inc. (RSSS) at Buy
- HSBC Starts Auna SA (AUNA) at Buy, 'Just what the doctor prescribed'
- Morgan Stanley Assumes Harley-Davidson (HOG) at Overweight, 'Freshly Tuned Up with Open Road Ahead'
Create E-mail Alert Related Categories
New CoverageRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
